AstraZeneca’s Brilinta Worse With High-Dose Aspirin Doses in Analysis
Linkedin

AstraZeneca’s Brilinta Worse With High-Dose Aspirin Doses in Analysis

London : United Kingdom | Jun 27, 2011 at 9:37 PM PDT
Source: PharmaGossip
XX XX
Views: Pending
 
AstraZeneca's Brilinta Worse With High-Dose Aspirin Doses in Analysis Heart patients taking AstraZeneca Plc (AZN) 's Brilinta blood-thinner and more than 300 milligrams of aspirin fared worse than those taking Sanofi and Bristol-Myers Squibb Co. (BMY) 's Plavix, according to a new analysis of... FULL ARTICLE AT PharmaGossip
1 of 1
US regulators want more information before deciding whether to approve a new AstraZeneca heart drug
US regulators want more information before deciding whether to approve a new AstraZeneca heart drug
 
  • Clear
  • Share:
  • Share
  • Clear
  • Clear
  • Clear
  • Clear
 
  • Credibility
  • Wait... Flag
 
 
Advertisement
 

News Stories

 

Images

 >
 

More From Allvoices



Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc. 2008-2014. All rights reserved. Powered by PulsePoint.